8¿ù 22ÀÏ(Åä¿äÀÏ) Room A |
½Ã°£ |
¼¼¼Ç |
ÁÂÀå/¿¬ÀÚ |
¼Ò¼Ó |
8:30-9:40 |
Symposium 3: Personalized Surgical Therapy for Thyroid Cancer |
Å°æ |
ÇѾçÀÇ´ë À̺ñÀÎÈÄ°ú |
8:30-8:45 |
Operative Management of Primary Papillary Thyroid Carcinoma |
±è¿Ï¿í |
°æºÏÀÇ´ë ¿Ü°ú |
8:45-9:00 |
Optimal Management for the Locally Invasive Thyroid Cancer |
¾È¼øÇö |
¼¿ïÀÇ´ë À̺ñÀÎÈÄ°ú |
9:00-9:15 |
Optimal Neck Dissection: How Much Surgery is Enough for the Node Positive Neck? |
À̺´ÁÖ |
ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú |
9:15-9:30 |
Intraoperative Neuromonitoring during Thyroid Surgery |
±èÈÆ¿± |
°í·ÁÀÇ´ë ¿Ü°ú |
9:45-10:55 |
Symposium 4: New Insight from Immunity to Thyroid Cancer |
ÀÌÀçÅ |
°æºÏÀÇ´ë ÇÙÀÇÇаú |
9:45-10:05 |
Immune Landscape of Papillary Thyroid Cancer and Immunotherapeutic Implications |
ÃÖÈ«À± |
¼¿ïÀÇ´ë ÇÙÀÇÇаú |
10:05-10:25 |
Co-Expression Network Analysis with Proteogenomics Identifies Important Transcriptional Factors in Tumorigenesis and Progression of BRAFV600E Mutated Thyroid Cancer |
±èÀ¯Çü |
¼¿ïÀÇ´ë ³»°ú |
10:25-10:45 |
Macrophage-Derived Endotrophin Supports Tumor Migration Potentials in Thyroid Cancer |
½ÅÈ¿½Ä |
¼¿ïÀÇ´ë ³»°ú |
10:55-11:15 |
Coffee Break |
¡¡ |
¡¡ |
11:15-12:15 |
Plenary Lecture |
ÀåÇ×¼® |
¿¬¼¼ÀÇ´ë ¿Ü°ú |
¡¡ |
Current Surgical Management of Thyroid Cancer in the United States |
Quan-Yang Duh |
University of California, San Francisco, USA |
12:15-12:45 |
ÃÑȸ |
¡¡ |
¡¡ |
12:45-13:15 |
Luncheon Symposium |
Á¤À±Àç |
Áß¾ÓÀÇ´ë ³»°ú |
¡¡ |
Metabolic Issues to Consider When Treating Patients with Thyroid Disease |
ÀÌÀº°æ |
±¹¸³¾Ï¼¾ÅÍ ³»°ú |
13:30-14:10 |
¹ü»ê Çмú»ó |
ÀÌ°´ë |
°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú(KTA ȸÀå) |
¡¡ |
Metastatic Follicular Carcinoma in Pelvic Cavity Arising from Struma Ovarii |
Á¤Á¾±æ |
¿©¼öÀü³²º´¿ø ¿Ü°ú |
14:15-15:00 |
Presidential Lecture |
¾Èº´Ã¶ |
°æºÏÀÇ´ë ÇÙÀÇÇаú |
¡¡ |
Development of New Technologies on the Preservation of the Parathyroid Gland and Recurrent Laryngeal Nerve during Thyroid and Parathyroid Surgery |
ÀÌ°´ë |
°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú |
15:00-15:20 |
Coffee Break |
¡¡ |
¡¡ |
15:20-16:30 |
Symposium 5: How to Deal with PTMC in Radiology |
³ªµ¿±Ô |
°¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú |
¼ºÁø¿ë |
´ë¸²¼º¸ðº´¿ø ¿µ»óÀÇÇаú |
15:20-15:40 |
Role of Thyroid US and CT in Active Surveillance of Low-Risk PTMC |
¾ÈÇý½Å |
Áß¾ÓÀÇ´ë ¿µ»óÀÇÇаú |
15:40-16:00 |
Interventional Management of Low-Risk PTMC |
ÇÏÀºÁÖ |
¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú |
16:00-16:20 |
Current Stance on Active Surveillance of Low-Risk PTMC |
¼Û¿µ±â |
¿ï»êÀÇ´ë ³»°ú |
16:35-17:45 |
Topic Highlight |
¾Èº´Ã¶ |
°æºÏÀÇ´ë ÇÙÀÇÇаú |
16:35-16:50 |
Long-Term Quality of Life According to the Treatment Options in Patients with Low Risk Papillary Thyroid Carcinoma - Results from the Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) |
¹®ÀçÈÆ |
¼¿ïÀÇ´ë ³»ºÐºñ³»°ú |
16:50-17:05 |
Radiomics Based on Thyroid Ultrasound Can Predict Distant Metastasis of Follicular Thyroid Carcinoma |
±Ç¹Ì¸® |
¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú |
17:05-17:20 |
Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry |
¾ÈÁ¾È |
¿ï»êÀÇ´ë ³»ºÐºñ³»°ú |
17:20-17:45 |
Adaptation of Murine Anaplastic Thyroid Cancer Cell Line from Hybrid Mice to Inbred C57BL/6 Mice |
ÇϼºÀ± |
¼¿ïÀÇ´ë Á¾¾ç»ý¹°Çаú |
17:45 |
Æóȸ ¹× ½Ã»ó½Ä |
¡¡ |
¡¡ |
|
8¿ù 22ÀÏ(Åä¿äÀÏ) Room B |
8:30-9:10 |
Free Paper 2 |
Á¤¼Ò·É |
°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú |
±èÀÎÁÖ |
ºÎ»êÀÇ´ë ³»°ú |
9:10-9:50 |
Free Paper 3 |
Á¶¿µ¼® |
¿¬¼¼ÀÇ´ë ³»°ú |
ÀÓÀÏÇÑ |
¿øÀڷº´¿ø ÇÙÀÇÇаú |